HOME >> MEDICINE >> NEWS
Shire's DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD

Philadelphia, PA, US and Basingstoke, UK -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) approved DAYTRANA (methylphenidate transdermal system), the first and only non-oral medication for the treatment of attention deficit hyperactivity disorder (ADHD). DAYTRANA, a once daily transdermal patch formulation of methylphenidate, will be available in 10 mg, 15 mg, 20 mg and 30 mg dosage strengths.

"The approval of DAYTRANA is important news for ADHD patients, their families and healthcare providers. In addition to being the only patch treatment for ADHD, it offers a convenient option to deliver medicine for those diagnosed with ADHD," said Shire Chief Executive Officer Matthew Emmens. "The addition of DAYTRANA to Shire's portfolio reaffirms our position as the market leader in ADHD."

Shire and Noven Pharmaceuticals, Inc. submitted an amended New Drug Application (NDA) for DAYTRANA to the FDA in June of last year. DAYTRANA is licensed globally to Shire by Noven and will be available in pharmacies in the U.S. in mid 2006.

The efficacy of DAYTRANA was established in two controlled clinical trials in children aged 6 to 12 years old with ADHD. DAYTRANA combines methylphenidate, a medication with a 50-year history of use, with Noven's patented DOT Matrix transdermal technology. This transdermal delivery system delivers medication directly through the skin into the bloodstream, and is designed to provide consistent, smooth drug release throughout the day. The patch is designed to stay on during the normal daily activities of a child, including swimming, exercising, and bathing. Because DAYTRANA is a patch, physicians can manage the duration of its effect and potential side effects by having the patient wear the patch for a shorter time period than the recommended 9 hour wear time on a given day. In clinical trials, wearing a DAYTRANA patch for 9 hours provided a duration of
'"/>

Contact: Matthew Cabrey, Shire
MCabrey@us.shire.com
484-595-8248
Porter Novelli
7-Apr-2006


Page: 1 2 3

Related medicine news :

1. Shires DAYTRANA, first patch medication for ADHD in children, now available in pharmacies
2. DAYTRANA (methylphenidate transdermal system) significant reduces ADHD symptoms
3. Positive study results for methylphenidate transdermal system
4. Positive study results for methylphenidate transdermal system
5. Four new us patents granted to Acrux for transdermal drug delivery
6. Novel catheter technique successfully patches holes in the heart
7. CankerMelts patches reduce pain and speed resolution of canker sores
8. Blood test predicts success of quitting smoking using the nicotine patch
9. Decent NHS care for older people still too patchy
10. Do testosterone patches help women with under-active pituitary glands?
11. Fentanyl patch safe and effective alternative to oral opioids for pediatric pain patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... ... being built in Westmoreland County, construction crews on Wednesday will lift into place ... expected to open its doors later this year. , The nearly 79,000-square-foot facility ...
(Date:2/19/2019)... ... February 19, 2019 , ... The American ... (CMAC). Originally developed and launched by the Center for Case Management in 2000, ... management administrators, managers, supervisors and leaders. , “I created the CMAC credential ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... of weight stigma in pregnant and postpartum women, a team led by a ... and early postpartum often show increased depressive symptoms, greater weight gain during pregnancy, ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... of advanced delivery technologies and development solutions for drugs, biologics and consumer ... will present at the annual US Bioassay Conference of the BioPharmaceutical Emerging ...
(Date:2/19/2019)... ... 19, 2019 , ... Tap water issues in the Jacksonville ... FL proudly serving over 3,500 satisfied customers. I’m looking forward to seeing the ... selling and installing our popular Water Filtration Systems," says Bob Novak, President of ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 20, 2019 , ... Mothers’ Milk Bank of North Texas ... of a new chapter for the nonprofit. , The building in southwest Fort Worth ... mission of improving the health and survival of premature and critically ill infants through ...
(Date:2/19/2019)... ... February 19, 2019 , ... RCH Solutions (RCH), a global provider of ... hiring of Frank Iafrato as Director of Sales and Business Development. Based out of ... throughout the Northeast region, building upon the momentum the firm established during a very ...
(Date:2/19/2019)... NEW YORK (PRWEB) , ... February 19, 2019 ... ... school-age children are dyslexic, and the International Dyslexia Association estimates that there are ... Rubin, creator of The Global Search for Education and founder of CMRubinWorld, Fredrik ...
Breaking Medicine Technology:
Cached News: